BioSpace News Archive

Policy

NEJM Calls for Change in U.S. Leadership Over ‘COVID-19 Failings’

As COVID-19 cases continue to rise in the United States, the editors of the prestigious New England Journal of Medicine have taken an unprecedented political stance and called for a change in political leadership this country.

October 8, 2020
·
3 min read
·
Alex Keown
Business

Corbus Eyes Restructuring Process as Lenabasum Continues to Fall Short

Funds will also be utilized to enhance Corbus’ pipeline of novel endocannabinoid system-targeting drug candidates, and the company’s workforce will be reduced by up to 54%.

October 8, 2020
·
3 min read
·
Krystle Vermes
Business

Pfizer-Lilly Endeavor Shows NGF Inhibitor Tanezumab Lowers Osteoarthritic Pain

Results from multiple Phase III trials show consistent improvements in pain relief and physical function.

October 8, 2020
·
4 min read
·
Gail Dutton
Drug Development

Amgen & Cytokinetics’ Cardiovascular Drug Disappoints in Phase III

The heart drug met primary endpoint but failed to make the ultimate impact needed.

October 8, 2020
·
2 min read
·
Kate Goodwin
Policy

Regeneron Requests Emergency Use Authorization for COVID-19 Antibody Cocktail

Regeneron stated that under its agreement with the U.S. government for initial doses of the cocktail, if an EUA is granted the government “has committed to making these doses available to the American people at no cost and would be responsible for their distribution.”

October 8, 2020
·
3 min read
·
Mark Terry
Genetown

Research Roundup: COVID-19 Pain Relief and More

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

October 8, 2020
·
5 min read
·
Mark Terry
What to Do If Your New Job Not Working Out

Whether the problem is the actual work itself, your co-workers, or the overall company atmosphere, you need to proactively take action if your new job not working out.

October 8, 2020
·
4 min read
·
Kymberlie Krieger
Business

BioSpace Movers & Shakers, Oct. 9

Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

October 8, 2020
·
6 min read
·
Alex Keown
Drug Development

Pfizer and OPKO’s Growth Hormone Drug Effective in Late-Stage Trial

Pfizer and Opko Health reported their Phase III clinical trial of somatrogan met the primary endpoint compared to Genotropin (somatropin) for treating children 3 to 18 years of age with growth hormone deficiency.

October 8, 2020
·
2 min read
·
Mark Terry
Policy

FDA Raises Concern Over Opioid Abuse Related to Alkermes’ Schizophrenia Drug

The assessment does point to a path for approval, however FDA staff do raise some concerns about the fact that the drug’s makeup includes an opioid antagonist.

October 8, 2020
·
2 min read
·
Alex Keown